Mustang Bio Alternatives & Competitors
12 companies similar to Mustang Bio — A fortress biotech Company
Companies similar to Mustang Bio
TScan Therapeutics
Unleash Immunity
Waltham, United States
Rocket Pharmaceuticals
Seeking gene therapy cures
Cranbury, United States
bluebird bio
Pursuing curative gene therapies to give patients and their families more bluebird days.
Somerville, United States
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
Rival Readout
Competing with Mustang Bio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Janux Therapeutics
Developing unique immunotherapies that generate tumor-specific immune responses to attack...
San Diego, United States
Outpace Bio
Revolutionizing Cell Therapy with Protein Design
Seattle, United States
Simcha Therapeutics
Overcoming biological challenges in clinically translatable pathways.
New Haven, United States
Thunder Biotech
MOTO-CAR®s: Innovative macrophage technology designed to provide effective treatment for p...
Provo, United States
Kiromic Biopharma, Inc.
Cell therapy company with end-to-end bioinformatic, AI targeting, and manufacturing techno...
Houston, United States
NEOGAP Therapeutics AB
Science for cure.
Stockholm, Sweden
American Gene Technologies® International Inc.
Our mission is to leverage the power of gene and cell therapy to reduce human suffering fr...
Rockville, United States
London, United Kingdom
About Mustang Bio
Mustang Bio, a clinical-stage bio-pharmaceutical entity founded in 2015, is strategically positioned within the United States as a specialized player in Biotechnology and Pharmaceutical industries. As a "A fortress biotech Company," Mustang is at the forefront of advancing medical breakthroughs through the development...
Development of Cell Therapies, Translating Breakthroughs into Treatments, Therapy Manufacturing
Patients with Difficult-to-Treat Cancers, Healthcare Providers, Pharmaceutical Partners
Clinical-stage Biopharmaceutical, Cell And Gene Therapies, Hematologic Cancers, Solid Tumors, Rare Genetic Diseases, CAR T Therapies, CRISPR/Cas9, Lentiviral Gene Therapy, XSCID, Cancer Immunotherapy, CD123, CD20, CS1, Patient Immune System, Novel Oncology Treatments
B2B
Licensing, Performance Based, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Mustang Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Mustang Bio on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
